Tailor Bio

Primary contact
Ketton Suite, The King Centre
Main Road, Barleythorpe, Oakham
LE15 7WD Rutland
United Kingdom
Ketton Suite, The King Centre
Main Road, Barleythorpe, Oakham
LE15 7WD Rutland
United Kingdom
Links
https://tailor.bio/
https://tailor.bio/
Diseases & Conditions Cancer
Technologies Artificial Intelligence
Funding 💰
Select investors Acequia Capital, Ascension, First In Ventures, Accelerate Cambridge, Innovate UK
Key people 🧑🤝🧑
- Jason Yip - Co-founder & CEO
- Dr. Geoff Macintyre - Co-founder & CSO
- Prof. Florian Markowetz - Co-founder & Director
- Prof. James Brenton - Co-founder & Director
- Dr. Ania Piskorz - Director
- Leon Chlon, PhD - Head of Drug Discovery
Highlights ⭐
- An unmet need: Many of the deadliest cancers share a common feature: extreme Chromosomal Instability (CIN). CIN manifests as an accumulation of structural and numerical chromosomal abnormalities in cancer cells. These changes result in chaotic genomes and are associated with metastasis, poor prognosis, and treatment resistance. While precision medicine approaches have improved the survival rates of many cancers, these improvements have been focussed on cancers without CIN. Cancers with extreme CIN have not seen significant improvements in overall survival. Therefore, there is an unmet need for treating cancers with extreme CIN.
- Opportunity: Tailor Bio's technology platform unlocks new methods of drug target discovery for the development of pan-cancer precision therapies. Additionally, it enables them to stratify patients according to their treatment response to different targeted therapies and chemotherapy.
- Great science team: Tailor Bio's team consists of scientific group leaders from the University of Cambridge, the Spanish National Cancer Institute and talented individuals committed to making a difference.
Video ▶️
Last update: April 15, 2023
Disclaimer: We can not guarantee that the information on this page is 100% correct. more